Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study

Key Points

• The study aims to evaluate the safety and effectiveness of a chemotherapy regimen in platinum-resistant epithelial ovarian cancer.
• Conducted a retrospective cohort analysis of patients receiving the chemotherapy regimen.
• Included patients with a history of treatment for ovarian cancer.
• Assessed the therapeutic efficacy and toxicity of nab-paclitaxel, nedaplatin, and bevacizumab.
• The chemotherapy regimen showed satisfactory therapeutic efficacy.
• Managed toxicity levels, indicating a viable treatment alternative for patients.